Gainers
- Anitra AZTR shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million.
- Oragenics OGEN shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million.
- PACS Group PACS shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion.
- MultiPlan MPLN shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million.
- Nanoviricides NNVC stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million.
- Calidi Biotherapeutics CLDI shares increased by 0.95% to $0.21. The company's market cap stands at $10.7 million.
Losers
- Matinas BioPharma Hldgs MTNB shares decreased by 4.2% to $0.15 during Wednesday's after-market session. The market value of their outstanding shares is at $38.7 million.
- Theriva Biologics TOVX stock declined by 3.19% to $0.27. The company's market cap stands at $4.6 million.
- Concord Medical Services CCM stock fell 2.66% to $1.1. The company's market cap stands at $47.7 million.
- Emergent BioSolutions EBS shares fell 2.4% to $6.51. The market value of their outstanding shares is at $341.1 million.
- Senseonics Holdings SENS stock declined by 2.28% to $0.43. The company's market cap stands at $228.2 million.
- Vicarious Surgical RBOT stock declined by 2.16% to $0.35. The company's market cap stands at $61.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CCMConcord Medical Services Holdings Ltd
$4.9913.9%
CLDICalidi Biotherapeutics Inc
--%
EBSEmergent BioSolutions Inc
$8.070.12%
MPLNMultiPlan Corp
$6.02-9.75%
MTNBMatinas BioPharma Holdings Inc
--%
NNVCNanoviricides Inc
$1.535.45%
OGENOragenics Inc
$0.3501-6.89%
PACSPACS Group Inc
$13.01-0.46%
RBOTVicarious Surgical Inc
$12.231.66%
SENSSenseonics Holdings Inc
--%
TOVXTheriva Biologics Inc
--%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in